Development and optimization of solid lipid nanoparticles coated with chitosan and poly(2-ethyl-2-oxazoline) for ocular drug delivery of ciprofloxacin

被引:40
|
作者
Onugwu, Adaeze L. [1 ,2 ]
Attama, Anthony A. [1 ,3 ]
Nnamani, Petra O. [1 ]
Onugwu, Sabastine O. [4 ]
Onuigbo, Ebele B. [3 ]
V. Khutoryanskiy, Vitaliy [2 ,5 ]
机构
[1] Univ Nigeria, Dept Pharmaceut, Drug Delivery & Nanomed Res Lab, Nsukka 410001, Enugu, Nigeria
[2] Univ Reading, Reading Sch Pharm, Reading RG6 6AD, England
[3] Univ Nigeria, Inst Drug Herbal Med & Excipient Res & Dev, Nsukka, Enugu, Nigeria
[4] Enugu State Univ Sci & Technol, Dept Pharmacognosy, Nsukka, Enugu, Nigeria
[5] Univ Nigeria, Dept Pharmaceut Microbiol & Biotechnol, Nsukka 410001, Enugu, Nigeria
关键词
Solid lipid nanoparticles poly(2-ethyl-2-oxazoline); Chitosan; Box-behnken design; Ciprofloxacin; Ocular delivery; CARRIERS; RELEASE; DISSOLUTION; FORMULATION; MECHANISM; SYSTEMS; DESIGN; EYE;
D O I
10.1016/j.jddst.2022.103527
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Many formulation strategies have been employed to improve ocular bioavailability of topical eye drops. The aim of this study was to develop and evaluate a series of solid lipid nanoparticles coated with poly(2-ethyl-2oxazoline) and chitosan for ocular delivery of ciprofloxacin. Ciprofloxacin-loaded poly(2-ethyl-2-oxazoline) (PSLN) formulation was prepared by a combination of melt-emulsion sonication and low-temperature solidification methods. A Box-Behnken design, was employed to statistically optimize the effects of the amount of drug (X1), lipid:polymer ratio (X2) and surfactant concentration (X3) on particle size (Y1) and entrapment efficiency (Y2). Analysis of variance was used to validate the optimization design; and regression equations and response surface plots were generated. The optimized formulation was selected through numerical point prediction approach. These nanoparticles were characterized using dynamic light scattering, transmission electron microscopy (TEM), differential scanning calorimetry (DSC), and powder X-ray diffractometry (PXRD). In vitro drug release and corneal permeation studies were carried out, while the mucoadhesive properties were evaluated ex vivo using porcine corneal tissue. The particle size and zeta potential of the optimized formulations ranged from 141 to 213 nm and +24.6 to-35.6 mV, respectively. PSLN possessed higher encapsulation efficiency than chitosan-coated solid lipid nanoparticles (CSLN). The in vitro drug release from all the formulations showed an initial burst release followed by prolonged release over 24 h. The release mechanism followed KorsemeyerPeppas model and Fickian diffusion (n < 0.5). DSC revealed lower enthalpy and crystallinity of the formulations as also detected by PXRD, while TEM showed spherical particles in the lower nanometer range with a layer of polymer coating. The results of this study demonstrated that CSLN exhibited higher mucoadhesion and retention on corneal tissues compared with PSLN and also showed higher flux and apparent permeability, but with lower entrapment efficiency.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] High molecular weight uniform poly(2-ethyl-2-oxazoline)
    Monnery, Bryn
    Hoogenboom, Richard
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
  • [22] Molecular simulation study on brushes of poly (2-ethyl-2-oxazoline)
    Kelich, Payam
    Asadinezhad, Ahmad
    MATERIALS TODAY COMMUNICATIONS, 2019, 21
  • [23] Formation of poly(2-ethyl-2-oxazoline) fibers in aqueous solutions
    Guener, Pinar Tatar
    Miko, Annamaria
    Demirel, A. Levent
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [24] Synthesis and characterization of degradable hyperbranched poly(2-ethyl-2-oxazoline)
    Ali, Muhammad Waqes
    Cheng, Siyuan
    Si, Jianhao
    Siddiq, Muhammad
    Ye, Xiaodong
    JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY, 2019, 57 (19) : 2030 - 2037
  • [25] Molecular shape of poly(2-ethyl-2-oxazoline) chains in THF
    Sung, JH
    Lee, DC
    POLYMER, 2001, 42 (13) : 5771 - 5779
  • [26] Poly(2-ethyl-2-oxazoline) Featuring a Central Amino Moiety
    Dirauf, Michael
    Fritz, Nicole
    Gottschaldt, Michael
    Weber, Christine
    Schubert, Ulrich S.
    MACROMOLECULAR RAPID COMMUNICATIONS, 2021, 42 (13)
  • [27] Star poly(2-ethyl-2-oxazoline)s - synthesis and thermosensitivity
    Kowalczuk, Agnieszka
    Kronek, Juraj
    Bosowska, Kornelia
    Trzebicka, Barbara
    Dworak, Andrzej
    POLYMER INTERNATIONAL, 2011, 60 (07) : 1001 - 1009
  • [28] Formulation of Carbopol®/Poly(2-ethyl-2-oxazoline)s Mucoadhesive Tablets for Buccal Delivery of Hydrocortisone
    Ruiz-Rubio, Leire
    Luz Alonso, Maria
    Perez-Alvarez, Leyre
    Maria Alonso, Rosa
    Luis Vilas, Jose
    Khutoryanskiy, Vitaliy V.
    POLYMERS, 2018, 10 (02):
  • [29] Poly(2-ethyl-2-oxazoline)-IR780 conjugate nanoparticles for breast cancer phototherapy
    Alves, Catia G.
    Lima-Sousa, Rita
    Melo, Bruna L.
    Ferreira, Paula
    Moreira, Andre F.
    Correia, Ilidio J.
    de Melo-Diogo, Duarte
    NANOMEDICINE, 2022, 17 (27) : 2057 - 2072
  • [30] Hydrogen bonded multilayers of poly(2-ethyl-2-oxazoline) stabilized silver nanoparticles and tannic acid
    Hendessi, Saman
    Guner, Pinar Tatar
    Miko, Annamaria
    Demirel, A. Levent
    EUROPEAN POLYMER JOURNAL, 2017, 88 : 666 - 678